Parkinson's Disease

The progression of Parkinson’s is characterized by a deterioration in motor control, and through a new study MIT researchers have explored how this might be monitored via a person’s walking patterns at home.

A hormone released by muscles during exercise has been found to reduce levels of a protein associated with Parkinson’s disease. The promising animal study indicates future therapies may be developed based on the way this hormone improves brain health.

A compelling study indicates Parkinson’s disease could be diagnosed by remotely tracking a person’s breathing patterns. Led by researchers from MIT, the study presents an AI system that uses radio waves to monitor breathing while a person sleeps.

New research reports some natural supplements contain high levels of levodopa, used in drug treatments for Parkinson’s disease. The research found levels of levodopa in some supplements can be higher than what's found in common pharmaceutical formulations.

Clumps of misfolded proteins that gather in the brain have been linked to neurodegenerative diseases like Parkinson’s. Now, newly identified nanobodies show promise in destabilizing the structure of these clumps, potentially leading to new treatments.

Scientists in Israel have demonstrated a promising new technology for early Parkinson's diagnosis, using a variation of MRI to spot tiny, telltale structures forming deep in the brain as the disease progresses.

New research has found an increased risk of several neurological disorders in patients following a bout of COVID-19. The study found the risk of Alzheimer’s, Parkinson’s and stroke all increased in COVID-positive subjects compared to those uninfected.

At the heart of much research into Parkinson's, both its causes and new forms of treatment, is a type of brain protein called alpha-synuclein, and new research has found that it appears to be leading a "double life."

Scientists have developed a promising new tool for monitoring Parkinson's treatment described as a "fluorescent nanosensor paint," which glows brightly in the presence of dopamine to reveal its concentrations and spread in the brain.

Scientists are making inroads when it comes to picking up the tell-tale signs of Parkinson's disease onset, and a new first-of-a-kind study has demonstrated how these might be revealed through an inexpensive blood test.

Among other things, people with Parkinson's disease suffer from a slowness of movement and a stiffness of the muscles. A new wearable device may help alleviate those symptoms, by buzzing the user in the chest.

Ever since doctors saw a spike in Parkinson’s disease cases following the 1918 flu pandemic scientists have studied the link between viral infection and neurodegeneration. Now, new research is presenting evidence COVID-19 may increase Parkinson's risk.